May 12, 2009
 

Biosite brand Triage Cardiac Panel


Biosite brand Triage Cardiac Panel
Use of affected lots of the Triage Cardiac Panel may lead to false negative results, possibly resulting in missed or incorrect diagnosis.
Source: www.fda.gov

FDA updates action on Plan B (levonorgestrel) tablets
FDA updates action on Plan B (levonorgestrel) tablets
Source: www.fda.gov

Rulemaking History for Nonprescription Products
Office of Nonprescription Products: Rulemaking History for Nonprescription Products (updated)
Source: www.fda.gov

Drug Shortages: Current Drug Shortages: Metoprolol succinate extended release tablets
Current Drug Shortages: Metoprolol succinate extended release tablets, see updated letter in Related Information Section
Source: www.fda.gov

Paragraph IV Patent Certifications
Office of Generic Drugs: Paragraph IV Patent Certifications (updated)
Source: www.fda.gov

FDA 101: Clinical Trials and Institutional Review Boards
Clinical trials test potential treatments in human volunteers to see whether they should be approved for wider use in the general population. A treatment could be a drug, medical device, or biologic, such as a vaccine, blood product, or gene therapy.
Source: www.fda.gov

Drug Shortages: Current Drug Shortages: Metoprolol succinate extended release tablets (updated)
Current Drug Shortages: Metoprolol succinate extended release tablets: See updated letter in Related Information Section
Source: www.fda.gov

Drugs@FDA Downloadable Data Files (updated)
Drugs@FDA Downloadable Data Files (updated)
Source: www.fda.gov

FDA updates the Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic and Myobloc
FDA updates the Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
Source: www.fda.gov

Drug Shortages: Current Drug Shortages: Mitomycin for injection (updated)
Current Drug Shortages: Mitomycin for injection: Ben Venue is shipping product, with allocation in effect, customer service: 1-800-562-4797
Source: www.fda.gov

Subscribe to Posts [Atom]